Clinical Trials Browser

OTHER_GOV × Interventional × lenvatinib × Clear all

Adrenocortical Carcinoma

NCT05832827 2023-10-23

Artemis

Phase 2 Recruiting

35 enrolled

Thoracic

Thymoma

NCT04519151 2023-06-08

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Phase 2 Recruiting

24 enrolled

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT05411757 2022-06-09

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Phase EARLY_PHASE1 Unknown

12 enrolled

Advanced Primary Liver Cancer

NCT05391867 2022-05-26

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Phase NA Unknown

70 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05162898 2022-01-27

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Phase NA Unknown

90 enrolled

Gastrointestinal

Liver Neoplasms

Clinical Trials

ACCOMPLISH

Artemis

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.